Disrupted rhythms of rest and wakefulness contribute to worse symptoms in schizophrenia patients
In a paper published today in Molecular Psychiatry, a team of scientists from the University of Pittsburgh in collaboration with…
In a paper published today in Molecular Psychiatry, a team of scientists from the University of Pittsburgh in collaboration with…
An international team of researchers including Sofya Kulikova, Senior Research Fellow at the HSE University-Perm, found that ketamine, being an NMDA receptor…
A study conducted by a group of Brazilian researchers contributes to a deeper understanding of the molecular basis for schizophrenia,…